Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Apr 15, 2026
Post-approval study’s primary cohort shows 70.2% target lesion primary patency consistent with pivotal randomized controlled trial results in a challenging population1
-
Mar 30, 2026
Company honored for creating the world's first Adaptive deep brain stimulation (aDBS) system for people with Parkinson's
-
Mar 29, 2026
Multicenter ALERT Trial demonstrates potential to advance treatment pathway to minimally invasive heart valve therapies for underserved patient populations
-
Mar 28, 2026
EMBRACE trial to study renal denervation with the Symplicity Spyral™ system and percutaneous coronary intervention (PCI) in the same procedure In SPYRAL HTN ON and OFF MED trials, patients...